NSEChange in Management1d ago · 17 Nov 2026, 05:51 pm

Change in Management

Onesource Specialty Pharma Limited · ONESOURCE

✦ AI SummaryMgmt Change

Onesource Specialty Pharma Limited has informed the Exchange about change in Management due to the resignation of Bernhard Thurnbauer, Chief Quality Officer and Senior Management Personnel, due to personal circumstances.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Onesource Specialty Pharma Limited has informed the Exchange about change in Management

Attachments (1)

📄

ONESOURCECDMO_17112026175127_OneSource_SE_Intimation.pdf

pdf

Download →
View document text
Corporate Office: Registered Office: Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A, Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi, 560076, India Navi Mumbai - 400703, India T: +91 80 6784 0738 T: +91 22 2789 2924 Date: November 17, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai- 400001 Bandra (E), Mumbai – 400 051 Scrip code: 544292 Scrip code: ONESOURCE Dear Sir/ Madam, Sub: Intimation of the resignation of Bernhard Thurnbauer, Chief Quality Officer (Senior Management Personnel) in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/ Madam, We wish to inform you that Bernhard Thurnbauer, Chief Quality Officer and Senior Management Personnel of the Company, has resigned from his position due to personal circumstances, with effect from the close of business hours on November 17, 2026. The disclosure pursuant to Regulation 30 of the SEBI Listing Regulations, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed herewith as Annexure A. Further, as required under Para A(7C) of Part A of Schedule III to the SEBI Listing Regulations, the resignation letter received from Bernhard Thurnbauer is enclosed herewith as Annexure B. This is for your information and records. For and on behalf of OneSource Specialty Pharma Limited Trisha A Company Secretary and Compliance Officer Membership Number: A47635 OneSource Specialty Pharma Limited Formerly Stelis Biopharma Limited info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497 Corporate Office: Registered Office: Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A, Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi, 560076, India Navi Mumbai - 400703, India T: +91 80 6784 0738 T: +91 22 2789 2924 Annexure – A Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026 Particulars Description Resignation due to personal circumstances of Reason for change viz. appointment, re-appointment, resignation, 1. relocating to Europe to be with his family removal, death or otherwise 2. Date of cessation November 17, 2026 3. Brief profile in case of appointment Not applicable Disclosure of relationship between directors (in case of appointment 4. Not Applicable of director) OneSource Specialty Pharma Limited Formerly Stelis Biopharma Limited info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497